Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762398 · ClinicalTrials.gov registry record
Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00762398: Clinical Trial study, sponsored by University of California, Irvine.
NCT00762398 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762398 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The Masimo monitor can measure hemoglobin level noninvasively and accuratly
Interventions
- DEVICE Masimo hemoglobin-meter
- BIOLOGICAL drawing blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-12 |
Why NCT00762398 stopped before completion
NCT00762398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Masimo hemoglobin-meter is the first listed.
NCT00762398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00762398 about?
NCT00762398 is a clinical study titled "Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients". The Masimo monitor can measure hemoglobin level noninvasively and accuratly
What is the current status of trial NCT00762398?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2008-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00762398?
The interventions under investigation include: Masimo hemoglobin-meter (DEVICE), drawing blood sample (BIOLOGICAL).
Who is sponsoring clinical trial NCT00762398?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia